Cargando…
Efficacy of Metformin as Adjuvant Therapy in Metastatic Breast Cancer Treatment
Background: Metformin has been reported to have an anti-tumorigenic impact against metastatic breast cancer (MBC) cells through several mechanisms. Its effect can be evaluated by using many variables such as the response rate (RR) as well as the progression-free survival (PFS). Materials and methods...
Autores principales: | Essa, Nourhan M., Salem, Heba F., Elgendy, Marwa O., Gabr, A., Omran, Mervat M., Hassan, Nivin A., Tashkandi, Hanaa M., Harakeh, Steve, Boshra, Marian S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572354/ https://www.ncbi.nlm.nih.gov/pubmed/36233373 http://dx.doi.org/10.3390/jcm11195505 |
Ejemplares similares
-
Combinatorial Network of Transcriptional and miRNA Regulation in Colorectal Cancer
por: Kumar, Rupesh, et al.
Publicado: (2023) -
Determination of the Cut-off Value for Imatinib Plasma Levels Linked to Occurrence of Bone Pain in CML Patients
por: Hamza, Marwa S, et al.
Publicado: (2022) -
A Bioengineered Quercetin-Loaded 3D Bio-Polymeric Graft for Tissue Regeneration and Repair
por: Dhasmana, Archna, et al.
Publicado: (2022) -
Network-based approach for targeting human kinases commonly associated with amyotrophic lateral sclerosis and cancer
por: Khatoon, Fatima, et al.
Publicado: (2022) -
Modulation of Plasma 25-Hydroxyvitamin D3 Level by Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia: The Role of Uptake and Efflux Transporters
por: Omran, Mervat M., et al.
Publicado: (2022)